A three-months period of electronic monitoring can provide important information to the healthcare team to assess adherence and improve asthma control
- Anja Jochmann1,2,
- Luca Artusio1,
- Jakob Usemann2,3,4,
- Angela Jamalzadeh1,
- Andrew Bush1,5,
- Urs Frey2 and
- Louise J. Fleming1,5⇑
- 1Department of Respiratory Paediatrics, Royal Brompton Hospital, London, UK
- 2University of Basel, University Children's Hospital (UKBB), Basel, Switzerland
- 3Division of Respiratory Medicine, University Children's Hospital Zurich, Zurich, Switzerland
- 4University of Basel, Basel, Switzerland
- 5National Heart and Lung Institute, Imperial College London, UK
- Dr Louise Fleming, Respiratory Paediatrics, Imperial College, London, Royal Brompton Hospital, Sydney Street, London SW3 6NP. E-mail: l.fleming{at}rbht.nhs.uk
Footnotes
This manuscript has recently been accepted for publication in the ERJ Open Research. It is published here in its accepted form prior to copyediting and typesetting by our production team. After these production processes are complete and the authors have approved the resulting proofs, the article will move to the latest issue of the ERJOR online. Please open or download the PDF to view this article.
Conflict of interest: Dr. Jochmann has nothing to disclose.
Conflict of interest: Dr. Artusio has nothing to disclose.
Conflict of interest: Dr. Usemann has nothing to disclose.
Conflict of interest: Dr. Jamalzadeh has nothing to disclose.
Conflict of interest: Dr. Bush has nothing to disclose.
Conflict of interest: Dr. Frey has nothing to disclose.
Conflict of interest: Dr. Fleming has nothing to disclose.
This is a PDF-only article. Please click on the PDF link above to read it.
- Received October 5, 2020.
- Accepted May 26, 2021.
- Copyright ©The authors 2021
This version is distributed under the terms of the Creative Commons Attribution Non-Commercial Licence 4.0. For commercial reproduction rights and permissions contact permissions{at}ersnet.org